Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs

(2017) Noel Frey et al.   EPILEPSIA

Assessing finasteride-associated sexual dysfunction using the FAERS database

(2017) A.K. Gupta et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Long-term Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

(2016) C Yang et al.   ACTA DERMATO-VENEREOLOGICA

Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults

(2016) Derek Y. Hsu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea

(2016) Min-Suk Yang et al.   PLoS One

Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society

(2015) A. Krumholz et al.   NEUROLOGY

Stevens–Johnson syndrome and toxic epidermal necrolysis: The Food and Drug Administration adverse event reporting system, 2004–2013

(2015) Junko Abe et al.   ALLERGOLOGY INTERNATIONAL

Stevens-Johnson Syndrome Associated with Drugs and Vaccines in Children: A Case-Control Study

(2014) Umberto Raucci et al.   PLoS One

Investigating psychotropic properties of antiepileptic drugs

(2013) Marco Mula   Expert Review of Neurotherapeutics

Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach

(2013) Amélie Marsot et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2013) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

(2013) Peggy Sekula et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Medications as Risk Factors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Pooled Analysis

(2009) N. Levi et al.   PEDIATRICS

Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect

(2008) Mara A. McAdams et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

(2007) Sima Halevy et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY